On 24 November 2020, LifeTech Scientific Corporation (the “Company”) noticed that Central Huijin Investment Ltd. (the parent company of China Everbright Limited) has transacted its entire equity interests in the Company to Hillhouse Capital and GL Capital. The two leading investment institutions both take the healthcare industry as their main focus, and they are both the professional investment institutions with the great international influence, taking the long-term and value- investing as their investment philosophy.

Upon the completion of the transaction, Hillhouse Capital and GL Capital aggregately held 6.06% and 6.00% of the total shares issued by the company respectively, becoming the important strategic partners of the company, and it is expected to accelerate the innovative products development and strengthen the international strategic layout of the Company.